ASX 200 healthcare shares led the market sectors last week with a 3.28% increase over the five trading days.
The S&P/ASX 200 Index (ASX: XJO) had a great start to the new financial year, rising 1.04% over the week to finish at 8,603 points.
Healthcare was partly propelled by a 9.73% surge for the unstoppable sector darling Pro Medicus Ltd (ASX: PME) shares.
For the first time ever, the Pro Medicus share price cracked the $300 mark last week, closing at $307.89 per share on Friday.
The stock set a new record at $316.47 on Thursday after the company announced two major contracts in the US.
Pro Medicus is now one of only two ASX 200 healthcare shares with a share price above $300.
The other is Cochlear Ltd (ASX: COH) shares.
As my colleague James explains, Pro Medicus has become a key player in the digitisation of global healthcare.
The company provides cloud-based radiology software to major hospital networks across the US, Europe, and Australia.
With high margins, zero debt, and a sticky client base, Pro Medicus continues to attract new contracts and report strong earnings growth.
Another colleague, Bernd, points out that we all could have invested in Pro Medicus shares for about $42 apiece just three years ago.
Let that painful truth sink in for a moment.
That is 625% share price growth.
Here is a visual aid.
In FY25, the Pro Medicus share price rose 99% to close at $285 per share on 30 June.
Pro Medicus was the second-best performer of the ASX 200 healthcare sector in FY25.
It was beaten by Sigma Healthcare Ltd (ASX: SIG) shares, which rose by 135% after the blockbuster Chemist Warehouse merger.
The S&P/ASX 200 Health Care Index (ASX: XHJ) declined in FY25, losing 6% in value.
Morgan Stanley and Bell Potter think Pro Medicus shares don't have much more room to grow.
Morgan Stanley has an overweight rating and a 12-month price target of $310 on Pro Medicus shares.
Last week, Bell Potter downgraded Pro Medicus from a buy to a hold rating with an improved price target of $320, up from $280.
Among the other ASX 200 healthcare sector heavyweights, CSL Ltd (ASX: CSL) shares lifted 3.59% to close at $242.76 on Friday.
Sigma shares gained 2.03% to close at $3.01 apiece.
The share price of private healthcare provider and hospital owner Ramsay Health Care Ltd (ASX: RHC) ripped 8.8% to $39.30.
The Cochlear Ltd (ASX: COH) share price rose 1.88% to $300.99.
Shares in pathology provider Sonic Healthcare Ltd (ASX: SHL) lifted 1.72% to close at $27.16 on Friday.
Resmed CDI (ASX: RMD) shares lifted 1.16% to $39.40 per share.
Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH) shares lifted 0.33% to $33.82 apiece.
Among the small-cap healthcare shares, Clarity Pharmaceuticals Ltd (ASX: CU6) rose 16.67% to close at $2.94 on Friday.
Here's how the 11 market sectors stacked up last week, according to CommSec data.
Over the five trading days:
| S&P/ASX 200 market sector | Change last week |
| Healthcare (ASX: XHJ) | 3.28% |
| A-REIT (ASX: XPJ) | 2.95% |
| Materials (ASX: XMJ) | 2.91% |
| Consumer Discretionary (ASX: XDJ) | 1.94% |
| Energy (ASX: XEJ) | 1.34% |
| Consumer Staples (ASX: XSJ) | 1.25% |
| Utilities (ASX: XUJ) | 1.11% |
| Industrials (ASX: XNJ) | 0.44% |
| Communication (ASX: XTJ) | (0.12%) |
| Information Technology (ASX: XIJ) | (0.16%) |
| Financials (ASX: XFJ) | (0.74%) |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.